4P Therapeutics
Business Services · Georgia, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
265 Park Ave NW, Atlanta, Georgia, 30303...Phone Number
(770) 263-1900Website
www.4ptherapeutics.comRevenue
<$5 MillionIndustry
About 4P Therapeutics
Is 4P Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
4P Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if 4P Therapeutics is spiking on competitors!
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when 4P Therapeutics launches new products
Check if 4P Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on 4P Therapeutics recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at 4P Therapeutics
Click to see if 4P Therapeutics had a recent Job posting/layoffs
Funding: Get notified immidiatlly once 4P Therapeutics has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Reach out to Masked Content who joined 4P Therapeutics as Masked Content
Find 2 more new buyers
Compare Similar Companies to 4P Therapeutics
Compare insights from companies similar to 4P Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
4P Therapeutics
Company Profile Activity
Activity Insights
4P Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
4P Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about 4P Therapeutics.
4P Therapeutics Tech Stack
A closer look at the technologies used by 4P Therapeutics
4P Therapeutics News & Media
Nutriband Inc.'s Abuse Deterrent Transdermal Technology Patent Granted by European Patent Office
ORLANDO, Fla., March 26, 2019 /PRNewswire/ -- Nutriband Inc. (OTCQB: NTRB), a Nevada corporation (the "Company"), announced today that the European Patent Office has granted full patent protection for European Patent Application EP15740893.1 entitled, "Abuse and Misuse Deterrent...Nutriband Inc. Granted Prioritized Examination from the United States Patent and Trademark Office for Abuse Deterrent Technology Patent Application
ORLANDO, Fla., Jan. 29, 2019 /PRNewswire/ -- Nutriband Inc. (OTCQB: NTRB), a Nevada corporation, announced today that the United States Patent and Trademark Office ("USPTO") has granted the Company's request for Prioritized Examination (Track One) of the U.S. patent application for "Abuse ...Small Cap Consumer Research Initiates Coverage of Nutriband Inc. in New Report
ORLANDO, Fla., Nov. 8, 2018 /PRNewswire/ -- Nutriband Inc. (OTCQB: NTRB), a pharmaceutical company developing and commercializing a portfolio of prescription pharmaceuticals, OTC's and consumer products based around the science of transdermal/topical technologies, is pleased to announce...Nutriband Inc. Receives 'Intention to Grant' Notice from European Patent Office for Abuse Deterrent Transdermal Technology Utilized in the Defentâ„¢ Abuse Deterrent Fentanyl Transdermal System
ORLANDO, Fla., Oct. 31, 2018 /PRNewswire/ -- Nutriband Inc. (OTCQB: NTRB), a Nevada corporation, announced today that the European Patent Office ("EPO") has issued a "Notice of Intention to Grant" for European Patent Application EP15740893.1 entitled, "Abuse and Misuse Deterrent...
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding 4P Therapeutics
4P Therapeutics is a clinical subsidiary of Nutriband Inc. that specializes in the research and development of innovative transdermal drug delivery technologies and therapeutics. The company focuses on creating products that cater to the needs of patients, physicians, and payers, particularly in the area of transdermal delivery for compounds typica... Read More